Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes
- DOI
- 10.1016/j.molmet.2021.101413
- Published
- 2022-01
- Container
- Molecular Metabolism
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.molmet.2021.101413,
title = {Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes},
author = {Chieh-Hsin Yang and Danise Ann-Onda and Xuzhu Lin and Stacey Fynch and Shaktypreya Nadarajah and Evan G. Pappas and Xin Liu and John W. Scott and Jonathan S. Oakhill and Sandra Galic and Yanchuan Shi and Alba Moreno-Asso and Cassandra Smith and Thomas Loudovaris and Itamar Levinger and Decio L. Eizirik and D. Ross Laybutt and Herbert Herzog and Helen E. Thomas and Kim Loh},
year = {2022},
journal = {Molecular Metabolism},
doi = {10.1016/j.molmet.2021.101413},
url = {https://doi.org/10.1016/j.molmet.2021.101413}
}RIS
TY - JOUR TI - Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes AU - Chieh-Hsin Yang AU - Danise Ann-Onda AU - Xuzhu Lin AU - Stacey Fynch AU - Shaktypreya Nadarajah AU - Evan G. Pappas AU - Xin Liu AU - John W. Scott AU - Jonathan S. Oakhill AU - Sandra Galic AU - Yanchuan Shi AU - Alba Moreno-Asso AU - Cassandra Smith AU - Thomas Loudovaris AU - Itamar Levinger AU - Decio L. Eizirik AU - D. Ross Laybutt AU - Herbert Herzog AU - Helen E. Thomas AU - Kim Loh PY - 2022 JO - Molecular Metabolism DO - 10.1016/j.molmet.2021.101413 UR - https://doi.org/10.1016/j.molmet.2021.101413 ER -
APA
Yang, C., Ann-Onda, D., Lin, X., Fynch, S., Nadarajah, S., Pappas, E. G., Liu, X., Scott, J. W., Oakhill, J. S., Galic, S., Shi, Y., Moreno-Asso, A., Smith, C., Loudovaris, T., Levinger, I., Eizirik, D. L., Laybutt, D. R., Herzog, H., Thomas, H. E., & Loh, K. (2022). Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes. Molecular Metabolism. https://doi.org/10.1016/j.molmet.2021.101413
Source records
- crossref · retrieved 2026-09-26T14:11:16.952Z